A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model

Journal: Nature Communications

Published: 2018-07-10

DOI: 10.1038/s41467-018-05127-2

Affiliations: 9

Authors: 22

Go to article
Institutions FC
Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan 0.32
Laboratory of Cell Signaling, UTokyo, Japan 0.20
Drug Discovery Initiative (DDI), UTokyo, Japan 0.16
Department of Life Science and Applied Chemistry, NITech, Japan 0.09
Graduate School of Pharmaceutical Sciences, Nagoya University, Japan 0.09
The University of Tokyo (UTokyo), Japan 0.05
Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan 0.03
RIKEN iPSC-based Drug Discovery and Development Team (IDDD), Japan 0.03
RIKEN Medical-risk Avoidance based on iPS Cells Team, Japan 0.03